Research overview based on the cited scientific literature.

Goal: Support tissue repair, wound healing, and angiogenesis through the active thymosin beta4 fragment mechanism[5][6].

Storage: Lyophilized frozen; reconstituted refrigerated; avoid freeze–thaw cycles of reconstituted solution.

Proper storage preserves peptide quality and activity.
Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure[7].
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); do not freeze reconstituted solution as freezing can denature peptides.
Allow vials to reach room temperature before opening to reduce condensation uptake.
Use reconstituted vials within 28 days when stored with bacteriostatic water preservative[8].

TB500 represents the Nterminal active fragment of thymosin beta4, specifically the heptapeptide sequence AcLKKTETQ[1][2]. This region is responsible for the actinbinding and cellmigration properties of the full thymosin molecule. Preclinical studies demonstrate that TB500 promotes angiogenesis, accelerates wound healing, and supports tissue regeneration by upregulating cell motility and blood vessel formation[5][6]. Research in animal models shows enhanced collagen deposition and reduced healing time in injury sites treated with thymosin fragments[11]. Recent metabolic studies suggest TB500 may act as a prodrug, cleaving to an active pentapeptide metabolite that drives biological activity[12].

Observations from preclinical and veterinary literature.
Supports accelerated wound healing and tissue repair through enhanced angiogenesis and cell migration[5][6].
May reduce inflammation and fibrosis indirectly via thymosin pathways observed in animal models[11].
Generally well tolerated in veterinary studies; occasional mild injectionsite reactions (redness, tenderness) reported.
Human safety data is limited; no largescale clinical trials have been completed for TB500 specifically[13].